Going into 2026, Cannabis is Becoming a Cornerstone of Modern Health Culture
Ten years ago, cannabis was associated with an underground counter-culture. Today, the plant is recognized as being an important part a full-blown wellness revolution that is shaping consumer health trends.
Botswana’s Key Development Challenges Are Landrace and Local Ownership of Cannabis Value Chain
Botswana’s ‘been in the news headlines lately with the release of its inaugural license fees and the Last Mile’ Conference in Gaborone last week to chart a way forward in creating a legal medical cannabis industry. SACHIDA’s Cian McLelland was a keynote speaker at the conference at which the importance of landrace was highlighted.
Pass the Dutchie….Medical Cannabis Legal in the Netherlands but Patient Access Remains a Challenge
The Dutch medical cannabis industry is struggling to match legality wth accessibility. A recent survey revealed the Netherlands has an estimated 500 000 people seeking to use cannabis for medical purposes but only 7 000 or so have actually managed to get prescriptions.
Botswana Last Mile Conference Looking to Establish Medical Cannabis Framework
Botswana hosts the First Mile Cannabis Conference on 30 January 2026 which puts medical cannabis on the map, now a hemp framework has been established. The Africa Canada Chamber of Commerce Conference and Expo will look specifically at how medical cannabis can fit into Botswana’s evolving cannabis development programme.
Medical Cannabis Gaining Popularity as a Treatment for Female Orgasmic Disorder
Over 41% of women reportedly have difficulty attaining orgasms and cannabis should be recognized as a treatment in matters of sexual health. This view is gaining ground in the US where medical cannabis is being used to treat Female Orgasmic Disorder in Illinois and Connecticut, with Oregon and New Mexico likely to follow suit .
Medical Cannabis Market Growth Fuelled by Success in Treating Pain, Anxiety, Epilepsy and Cancer-Related Conditions
The pharmacy industry occupies 61% of the international medical cannabis market is investing heavily in the development of new drugs, particularly for chronic pain, epilepsy and cancer-related conditions. That’s according to the World Cannabis Report 2026.
International Medical Cannabis Market Growing at 23% a Year as Regulations Loosen and Patients Seek Alternative Therapies
One of the reasons behind the surging global growth in medical cannabis is the demand by consumers for alternatives to opioids. That, along with better regulatory frameworks and more research on the therapeutic benefits of cannabis, are the main drivers behind the growth of the US$30 billion market
‘Blockbuster’ Cannabis Drug for Chronic Lower Back Pain Set for Release in 2026
The first cannabis-derived product for chronic lower back pain VER-01, is to be launched this year by German pharmaceutical company Vertanical, It claims the new product is twice as effective as existing treatments and opens up a new and uncontroversial pathway for cannabis prescriptions.
Statement from the White House: Increasing Medical Marijuana and Cannabidiol Research.
This is the statement issued by the White House on 18 December 2025, accepting the medical benefits of cannabis and rescheduling its classification as a less dangerous drug. Although this does not allow federal legalization, the executive order is a deeply significant step in US cannabis reform.
Medical Cannabis Marketing Now Positioning Cannabis as a Mainstream Healthcare Product Rather than Alternative Medicine
Leading international cannabis consultancy Prohibition Partners says the European medical cannabis market is maturing at speed, with providers focused on return on investment and a shift in marketing strategies. Cannabis is already well-known as an ‘alternative medicine’, but now marketing departments are looking at repositioning it as part of a cannabis ‘standardized healthcare’ package.